ArticleActa pharmacologica Sinica2025

Oral FPR2/ALX modulators tune myeloid cell activity to ameliorate mucosal inflammation in inflammatory bowel disease.

Wen-Sheng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.